Kirkland & Ellis and Freshfields Bruckhaus Deringer have advised on the $5bn (£3.3bn) acquisition of German drugmaker Ratiopharm by Teva Pharmaceuticals, the world's leading generic drug company, reports The Am Law Daily. Kirkland took a lead role for Teva on the deal, while Freshfields advised Ratiopharm's parent company, with partners Andreas Fabritius and Oliver von Rosenberg leading the magic circle firm's team.
March 19, 2010 at 06:43 AM
1 minute read
The original version of this story was published on Legalweek
Kirkland & Ellis and Freshfields Bruckhaus Deringer have advised on the $5bn (£3.3bn) acquisition of German drugmaker Ratiopharm by Teva Pharmaceuticals, the world’s leading generic drug company, reports The Am Law Daily.
Kirkland took a lead role for Teva on the deal, while Freshfields advised Ratiopharm’s parent company, with partners Andreas Fabritius and Oliver von Rosenberg leading the magic circle firm’s team.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
